Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
7.
JAAD Case Rep ; 37: 114-115, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37396485
9.
JAMA Oncol ; 9(9): 1291-1292, 2023 09 01.
Article in English | MEDLINE | ID: mdl-37471070

ABSTRACT

A 56-year-old woman was admitted for myeloablative conditioning in preparation for allogeneic hematopoietic cell transplant. Her course was complicated by severe mucositis, acute kidney injury, and neutropenic fever. During her admission, she also developed painful necrotic skin lesions, a nonproductive cough, and altered mental status. What is your diagnosis?


Subject(s)
Hematopoietic Stem Cell Transplantation , Female , Humans , Aged , Pain/etiology
11.
Nature ; 616(7957): 448-451, 2023 04.
Article in English | MEDLINE | ID: mdl-36858072

ABSTRACT

The Double Asteroid Redirection Test (DART) spacecraft successfully performed the first test of a kinetic impactor for asteroid deflection by impacting Dimorphos, the secondary of near-Earth binary asteroid (65803) Didymos, and changing the orbital period of Dimorphos. A change in orbital period of approximately 7 min was expected if the incident momentum from the DART spacecraft was directly transferred to the asteroid target in a perfectly inelastic collision1, but studies of the probable impact conditions and asteroid properties indicated that a considerable momentum enhancement (ß) was possible2,3. In the years before impact, we used lightcurve observations to accurately determine the pre-impact orbit parameters of Dimorphos with respect to Didymos4-6. Here we report the change in the orbital period of Dimorphos as a result of the DART kinetic impact to be -33.0 ± 1.0 (3σ) min. Using new Earth-based lightcurve and radar observations, two independent approaches determined identical values for the change in the orbital period. This large orbit period change suggests that ejecta contributed a substantial amount of momentum to the asteroid beyond what the DART spacecraft carried.

12.
Nature ; 616(7957): 452-456, 2023 04.
Article in English | MEDLINE | ID: mdl-36858074

ABSTRACT

Some active asteroids have been proposed to be formed as a result of impact events1. Because active asteroids are generally discovered by chance only after their tails have fully formed, the process of how impact ejecta evolve into a tail has, to our knowledge, not been directly observed. The Double Asteroid Redirection Test (DART) mission of NASA2, in addition to having successfully changed the orbital period of Dimorphos3, demonstrated the activation process of an asteroid resulting from an impact under precisely known conditions. Here we report the observations of the DART impact ejecta with the Hubble Space Telescope from impact time T + 15 min to T + 18.5 days at spatial resolutions of around 2.1 km per pixel. Our observations reveal the complex evolution of the ejecta, which are first dominated by the gravitational interaction between the Didymos binary system and the ejected dust and subsequently by solar radiation pressure. The lowest-speed ejecta dispersed through a sustained tail that had a consistent morphology with previously observed asteroid tails thought to be produced by an impact4,5. The evolution of the ejecta after the controlled impact experiment of DART thus provides a framework for understanding the fundamental mechanisms that act on asteroids disrupted by a natural impact1,6.

14.
Clin Infect Dis ; 76(10): 1843-1846, 2023 May 24.
Article in English | MEDLINE | ID: mdl-36718662

ABSTRACT

In the current mpox outbreak, infections are usually self-limited. We describe 3 patients with uncontrolled HIV and mpox infections lasting months, causing debilitating lesions, complications, and death, despite initiating anti-mpox and antiretroviral therapy. Delayed treatment of mpox with antiviral agents may contribute to poor outcomes in severely immunocompromised patients.


Subject(s)
HIV Infections , HIV , Mpox (monkeypox) , Humans , Antiviral Agents/therapeutic use , Disease Outbreaks , HIV Infections/complications , HIV Infections/drug therapy , Mpox (monkeypox)/complications
15.
Diagnostics (Basel) ; 12(8)2022 Aug 19.
Article in English | MEDLINE | ID: mdl-36010360

ABSTRACT

BACKGROUND: Cutaneous manifestations of systemic diseases are diverse and sometimes precede more serious diseases and symptomatology. Similarly, radiologic imaging plays a key role in early diagnosis and determination of the extent of systemic involvement. Simultaneous awareness of skin and imaging manifestations can help the radiologist to narrow down differential diagnosis even if imaging findings are nonspecific. AIMS: To improve diagnostic accuracy and patient care, it is important that clinicians and radiologists be familiar with both cutaneous and radiologic features of various systemic disorders. This article reviews cutaneous manifestations and imaging findings of commonly encountered systemic diseases. CONCLUSIONS: Familiarity with the most disease-specific skin lesions help the radiologist pinpoint a specific diagnosis and consequently, in preventing unnecessary invasive workups and contributing to improved patient care.

16.
Transpl Infect Dis ; 24(3): e13830, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35325503

ABSTRACT

Deep dermatophytosis is an uncommon fungal infection of the dermis most often seen in the setting of immunocompromise. We report a case of trichophyton deep dermatophytosis in a patient with a history of orthotopic heart transplantation who presented with superficial white onychomycosis and papules and plaques on the legs.


Subject(s)
Heart Transplantation , Onychomycosis , Tinea , Heart Transplantation/adverse effects , Humans , Onychomycosis/diagnosis , Onychomycosis/drug therapy , Tinea/diagnosis , Tinea/drug therapy , Tinea/microbiology , Trichophyton
17.
BMJ ; 376: e067649, 2022 03 24.
Article in English | MEDLINE | ID: mdl-35331991

Subject(s)
Lymphangitis , Humans
19.
Pediatr Dermatol ; 38(2): 431-435, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33486822

ABSTRACT

BACKGROUND/OBJECTIVES: Efficacy and safety data of scabies treatments in infants are limited. Although topical permethrin is used in the treatment of scabies in adults, it is not approved for use in infants younger than 2 months of age in many parts of the world. This study aimed to describe treatment practices in the management of scabies in infants younger than 2 months. METHODS: An online survey was developed and distributed to physicians worldwide through the Society of Pediatric Dermatology and the Pediatric Dermatology Research Alliance. Data collected included demographics, medication availability, experience using medications, deterrents to medication use, medication administration preferences, perceived and experienced medication side effects, and preferred treatment agent in this population. RESULTS: In total, 57 physicians from seven countries responded. The majority of respondents were board-certified in pediatric dermatology (48/57, 84.2%) and resided in the United States (44/57, 77.2%). Respondents had experience using permethrin (47/57, 82.5%) and precipitated sulfur (35/57, 61.4%) most frequently. Most (38/57, 66.7%) preferred permethrin as their treatment of choice. Among those who did not use permethrin, potential side effects (8/10, 80%) were most frequently reported as a deterrent from its use. However, only 4.3% (22/47) of those who used permethrin reported side effects, including itching, erythema, and xerosis. CONCLUSIONS: Permethrin is frequently used in the treatment of infants younger than 2 months with scabies. Furthermore, our results demonstrate that permethrin is the preferred treatment agent among sampled dermatologists for infants younger than 2 months. Few side effects were reported, and none were serious.


Subject(s)
Dermatology , Insecticides , Scabies , Adult , Child , Humans , Infant , Ivermectin , Permethrin , Pruritus , Scabies/drug therapy , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...